Translational Oncology (Jul 2023)

Metastatic breast tumors downregulate miR-145 regulating the hypoxia-induced vasculogenic mimicry

  • Estefania Contreras-Sanzón,
  • Ángeles Carlos-Reyes,
  • Mónica Sierra-Martínez,
  • Gustavo Acosta-Altamirano,
  • Cesar Luna-Rivero,
  • David Núñez-Corona,
  • Alejandra Paola García-Hernández,
  • Eloisa Ibarra-Sierra,
  • Horacio Vidrio-Morgado,
  • María Elizbeth Alvarez-Sánchez,
  • Laurence A. Marchat,
  • César López-Camarillo

Journal volume & issue
Vol. 33
p. 101680

Abstract

Read online

Tumor cells grow in three-dimensional (3D) channels-like structures denoted as vasculogenic mimicry (VM), which provides a route for nutrients and oxygen acquisition. VM is activated by hypoxia and associated with metastasis and poor prognosis. MetastamiRs are microRNAs regulating metastasis, however, if they control VM in breast cancer remains poorly understood. The aim of this study was to evaluate the expression of VM-associated microRNAs in tumors of metastatic breast cancer patients. Firstly, we constructed microRNAs/mRNAs coregulation networks using expression data from TCGA databases. Dozens of microRNAs regulating genes involved in VM and metastasis were found. Of these, we selected 10 microRNAs for further characterization. The presence of VM in histological samples from patients with or without metastasis was evaluated using CD31-/PAS+ immunophenotyping. Remarkably, data showed that VM was significantly increased in tumors from patients with metastasis in comparison with no-metastatic group. Gene expression analysis indicated that miR-145, miR-142-3p, miR-31, miR-148a, miR-200b-3p and miR-526b were downregulated in primary tumors from patients with metastatic disease and positive for VM. Moreover, modulated microRNAs showed a predictive clinical value in overall survival in a cohort (n=1262) of breast cancer patients. Of these, we evaluated the role of miR-145 in formation of hypoxia-induced 3D channels-like using an in vitro model that recapitulates the early stages of VM. Data showed that miR-145 mimics was able to abolish the VM development in both metastatic Hs578t and MDA-MB-231 breast cancer cells. In conclusion, manipulation of miR-145 levels may represent a therapeutic approach in metastatic breast cancer patients that developed VM.

Keywords